Global NK Cells Market Research Report 2023

The global NK Cells market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for NK Cells is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for NK Cells is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of NK Cells include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for NK Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NK Cells.

The NK Cells market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global NK Cells market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NK Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of NK Cells

1.2 NK Cells Segment by Type

1.2.1 Global NK Cells Market Value Comparison by Type (2023-2029)

1.2.2 Mogamulizumab

1.2.3 Lorvotuzumab Mertansine

1.2.4 Others

1.3 NK Cells Segment by Application

1.3.1 Global NK Cells Market Value by Application: (2023-2029)

1.3.2 Cancer

1.3.3 Cardiovascular Diseases

1.3.4 Others

1.4 Global NK Cells Market Size Estimates and Forecasts

1.4.1 Global NK Cells Revenue 2018-2029

1.4.2 Global NK Cells Sales 2018-2029

1.4.3 Global NK Cells Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global NK Cells Sales Market Share by Manufacturers (2018-2023)

2.2 Global NK Cells Revenue Market Share by Manufacturers (2018-2023)

2.3 Global NK Cells Average Price by Manufacturers (2018-2023)

2.4 Global NK Cells Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of NK Cells, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of NK Cells, Product Type & Application

2.7 NK Cells Market Competitive Situation and Trends

2.7.1 NK Cells Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest NK Cells Players Market Share by Revenue

2.7.3 Global NK Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global NK Cells Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global NK Cells Global NK Cells Sales by Region: 2018-2029

3.2.1 Global NK Cells Sales by Region: 2018-2023

3.2.2 Global NK Cells Sales by Region: 2024-2029

3.3 Global NK Cells Global NK Cells Revenue by Region: 2018-2029

3.3.1 Global NK Cells Revenue by Region: 2018-2023

3.3.2 Global NK Cells Revenue by Region: 2024-2029

3.4 North America NK Cells Market Facts & Figures by Country

3.4.1 North America NK Cells Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America NK Cells Sales by Country (2018-2029)

3.4.3 North America NK Cells Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe NK Cells Market Facts & Figures by Country

3.5.1 Europe NK Cells Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe NK Cells Sales by Country (2018-2029)

3.5.3 Europe NK Cells Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific NK Cells Market Facts & Figures by Country

3.6.1 Asia Pacific NK Cells Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific NK Cells Sales by Country (2018-2029)

3.6.3 Asia Pacific NK Cells Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America NK Cells Market Facts & Figures by Country

3.7.1 Latin America NK Cells Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America NK Cells Sales by Country (2018-2029)

3.7.3 Latin America NK Cells Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa NK Cells Market Facts & Figures by Country

3.8.1 Middle East and Africa NK Cells Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa NK Cells Sales by Country (2018-2029)

3.8.3 Middle East and Africa NK Cells Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4.1 Global NK Cells Sales by Type (2018-2029)

4.1.1 Global NK Cells Sales by Type (2018-2023)

4.1.2 Global NK Cells Sales by Type (2024-2029)

4.1.3 Global NK Cells Sales Market Share by Type (2018-2029)

4.2 Global NK Cells Revenue by Type (2018-2029)

4.2.1 Global NK Cells Revenue by Type (2018-2023)

4.2.2 Global NK Cells Revenue by Type (2024-2029)

4.2.3 Global NK Cells Revenue Market Share by Type (2018-2029)

4.3 Global NK Cells Price by Type (2018-2029)

5.1 Global NK Cells Sales by Application (2018-2029)

5.1.1 Global NK Cells Sales by Application (2018-2023)

5.1.2 Global NK Cells Sales by Application (2024-2029)

5.1.3 Global NK Cells Sales Market Share by Application (2018-2029)

5.2 Global NK Cells Revenue by Application (2018-2029)

5.2.1 Global NK Cells Revenue by Application (2018-2023)

5.2.2 Global NK Cells Revenue by Application (2024-2029)

5.2.3 Global NK Cells Revenue Market Share by Application (2018-2029)

5.3 Global NK Cells Price by Application (2018-2029)

6.1 Chipscreen Biosciences

6.1.1 Chipscreen Biosciences Corporation Information

6.1.2 Chipscreen Biosciences Description and Business Overview

6.1.3 Chipscreen Biosciences NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Chipscreen Biosciences NK Cells Product Portfolio

6.1.5 Chipscreen Biosciences Recent Developments/Updates

6.2 Affimed NV

6.2.1 Affimed NV Corporation Information

6.2.2 Affimed NV Description and Business Overview

6.2.3 Affimed NV NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Affimed NV NK Cells Product Portfolio

6.2.5 Affimed NV Recent Developments/Updates

6.3 Altor BioScience

6.3.1 Altor BioScience Corporation Information

6.3.2 Altor BioScience Description and Business Overview

6.3.3 Altor BioScience NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Altor BioScience NK Cells Product Portfolio

6.3.5 Altor BioScience Recent Developments/Updates

6.4 Innate Pharma

6.4.1 Innate Pharma Corporation Information

6.4.2 Innate Pharma Description and Business Overview

6.4.3 Innate Pharma NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Innate Pharma NK Cells Product Portfolio

6.4.5 Innate Pharma Recent Developments/Updates

6.5 Takeda

6.5.1 Takeda Corporation Information

6.5.2 Takeda Description and Business Overview

6.5.3 Takeda NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Takeda NK Cells Product Portfolio

6.5.5 Takeda Recent Developments/Updates

6.6 Sorrento Therapeutics

6.6.1 Sorrento Therapeutics Corporation Information

6.6.2 Sorrento Therapeutics Description and Business Overview

6.6.3 Sorrento Therapeutics NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Sorrento Therapeutics NK Cells Product Portfolio

6.6.5 Sorrento Therapeutics Recent Developments/Updates

6.7 NantKwest

6.6.1 NantKwest Corporation Information

6.6.2 NantKwest Description and Business Overview

6.6.3 NantKwest NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.4.4 NantKwest NK Cells Product Portfolio

6.7.5 NantKwest Recent Developments/Updates

6.8 Bristol-Myers Squibb

6.8.1 Bristol-Myers Squibb Corporation Information

6.8.2 Bristol-Myers Squibb Description and Business Overview

6.8.3 Bristol-Myers Squibb NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Bristol-Myers Squibb NK Cells Product Portfolio

6.8.5 Bristol-Myers Squibb Recent Developments/Updates

6.9 NKT

6.9.1 NKT Corporation Information

6.9.2 NKT Description and Business Overview

6.9.3 NKT NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.9.4 NKT NK Cells Product Portfolio

6.9.5 NKT Recent Developments/Updates

6.10 Henry Ford Health Services

6.10.1 Henry Ford Health Services Corporation Information

6.10.2 Henry Ford Health Services Description and Business Overview

6.10.3 Henry Ford Health Services NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Henry Ford Health Services NK Cells Product Portfolio

6.10.5 Henry Ford Health Services Recent Developments/Updates

6.11 Fortress Biotech

6.11.1 Fortress Biotech Corporation Information

6.11.2 Fortress Biotech NK Cells Description and Business Overview

6.11.3 Fortress Biotech NK Cells Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Fortress Biotech NK Cells Product Portfolio

6.11.5 Fortress Biotech Recent Developments/Updates

7.1 NK Cells Industry Chain Analysis

7.2 NK Cells Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 NK Cells Production Mode & Process

7.4 NK Cells Sales and Marketing

7.4.1 NK Cells Sales Channels

7.4.2 NK Cells Distributors

7.5 NK Cells Customers

8.1 NK Cells Industry Trends

8.2 NK Cells Market Drivers

8.3 NK Cells Market Challenges

8.4 NK Cells Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global NK Cells Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global NK Cells Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global NK Cells Market Competitive Situation by Manufacturers in 2022

    Table 4. Global NK Cells Sales (g) of Key Manufacturers (2018-2023)

    Table 5. Global NK Cells Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global NK Cells Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global NK Cells Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market NK Cells Average Price (USD/g) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of NK Cells, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of NK Cells, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of NK Cells, Product Type & Application

    Table 12. Global Key Manufacturers of NK Cells, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global NK Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cells as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global NK Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global NK Cells Sales by Region (2018-2023) & (g)

    Table 18. Global NK Cells Sales Market Share by Region (2018-2023)

    Table 19. Global NK Cells Sales by Region (2024-2029) & (g)

    Table 20. Global NK Cells Sales Market Share by Region (2024-2029)

    Table 21. Global NK Cells Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global NK Cells Revenue Market Share by Region (2018-2023)

    Table 23. Global NK Cells Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global NK Cells Revenue Market Share by Region (2024-2029)

    Table 25. North America NK Cells Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America NK Cells Sales by Country (2018-2023) & (g)

    Table 27. North America NK Cells Sales by Country (2024-2029) & (g)

    Table 28. North America NK Cells Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America NK Cells Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe NK Cells Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe NK Cells Sales by Country (2018-2023) & (g)

    Table 32. Europe NK Cells Sales by Country (2024-2029) & (g)

    Table 33. Europe NK Cells Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe NK Cells Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific NK Cells Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific NK Cells Sales by Region (2018-2023) & (g)

    Table 37. Asia Pacific NK Cells Sales by Region (2024-2029) & (g)

    Table 38. Asia Pacific NK Cells Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific NK Cells Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America NK Cells Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America NK Cells Sales by Country (2018-2023) & (g)

    Table 42. Latin America NK Cells Sales by Country (2024-2029) & (g)

    Table 43. Latin America NK Cells Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America NK Cells Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa NK Cells Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa NK Cells Sales by Country (2018-2023) & (g)

    Table 47. Middle East & Africa NK Cells Sales by Country (2024-2029) & (g)

    Table 48. Middle East & Africa NK Cells Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa NK Cells Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global NK Cells Sales (g) by Type (2018-2023)

    Table 51. Global NK Cells Sales (g) by Type (2024-2029)

    Table 52. Global NK Cells Sales Market Share by Type (2018-2023)

    Table 53. Global NK Cells Sales Market Share by Type (2024-2029)

    Table 54. Global NK Cells Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global NK Cells Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global NK Cells Revenue Market Share by Type (2018-2023)

    Table 57. Global NK Cells Revenue Market Share by Type (2024-2029)

    Table 58. Global NK Cells Price (USD/g) by Type (2018-2023)

    Table 59. Global NK Cells Price (USD/g) by Type (2024-2029)

    Table 60. Global NK Cells Sales (g) by Application (2018-2023)

    Table 61. Global NK Cells Sales (g) by Application (2024-2029)

    Table 62. Global NK Cells Sales Market Share by Application (2018-2023)

    Table 63. Global NK Cells Sales Market Share by Application (2024-2029)

    Table 64. Global NK Cells Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global NK Cells Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global NK Cells Revenue Market Share by Application (2018-2023)

    Table 67. Global NK Cells Revenue Market Share by Application (2024-2029)

    Table 68. Global NK Cells Price (USD/g) by Application (2018-2023)

    Table 69. Global NK Cells Price (USD/g) by Application (2024-2029)

    Table 70. Chipscreen Biosciences Corporation Information

    Table 71. Chipscreen Biosciences Description and Business Overview

    Table 72. Chipscreen Biosciences NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 73. Chipscreen Biosciences NK Cells Product

    Table 74. Chipscreen Biosciences Recent Developments/Updates

    Table 75. Affimed NV Corporation Information

    Table 76. Affimed NV Description and Business Overview

    Table 77. Affimed NV NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 78. Affimed NV NK Cells Product

    Table 79. Affimed NV Recent Developments/Updates

    Table 80. Altor BioScience Corporation Information

    Table 81. Altor BioScience Description and Business Overview

    Table 82. Altor BioScience NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 83. Altor BioScience NK Cells Product

    Table 84. Altor BioScience Recent Developments/Updates

    Table 85. Innate Pharma Corporation Information

    Table 86. Innate Pharma Description and Business Overview

    Table 87. Innate Pharma NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 88. Innate Pharma NK Cells Product

    Table 89. Innate Pharma Recent Developments/Updates

    Table 90. Takeda Corporation Information

    Table 91. Takeda Description and Business Overview

    Table 92. Takeda NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 93. Takeda NK Cells Product

    Table 94. Takeda Recent Developments/Updates

    Table 95. Sorrento Therapeutics Corporation Information

    Table 96. Sorrento Therapeutics Description and Business Overview

    Table 97. Sorrento Therapeutics NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 98. Sorrento Therapeutics NK Cells Product

    Table 99. Sorrento Therapeutics Recent Developments/Updates

    Table 100. NantKwest Corporation Information

    Table 101. NantKwest Description and Business Overview

    Table 102. NantKwest NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 103. NantKwest NK Cells Product

    Table 104. NantKwest Recent Developments/Updates

    Table 105. Bristol-Myers Squibb Corporation Information

    Table 106. Bristol-Myers Squibb Description and Business Overview

    Table 107. Bristol-Myers Squibb NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 108. Bristol-Myers Squibb NK Cells Product

    Table 109. Bristol-Myers Squibb Recent Developments/Updates

    Table 110. NKT Corporation Information

    Table 111. NKT Description and Business Overview

    Table 112. NKT NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 113. NKT NK Cells Product

    Table 114. NKT Recent Developments/Updates

    Table 115. Henry Ford Health Services Corporation Information

    Table 116. Henry Ford Health Services Description and Business Overview

    Table 117. Henry Ford Health Services NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 118. Henry Ford Health Services NK Cells Product

    Table 119. Henry Ford Health Services Recent Developments/Updates

    Table 120. Fortress Biotech Corporation Information

    Table 121. Fortress Biotech Description and Business Overview

    Table 122. Fortress Biotech NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)

    Table 123. Fortress Biotech NK Cells Product

    Table 124. Fortress Biotech Recent Developments/Updates

    Table 125. Key Raw Materials Lists

    Table 126. Raw Materials Key Suppliers Lists

    Table 127. NK Cells Distributors List

    Table 128. NK Cells Customers List

    Table 129. NK Cells Market Trends

    Table 130. NK Cells Market Drivers

    Table 131. NK Cells Market Challenges

    Table 132. NK Cells Market Restraints

    Table 133. Research Programs/Design for This Report

    Table 134. Key Data Information from Secondary Sources

    Table 135. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of NK Cells

    Figure 2. Global NK Cells Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global NK Cells Market Share by Type in 2022 & 2029

    Figure 4. Mogamulizumab Product Picture

    Figure 5. Lorvotuzumab Mertansine Product Picture

    Figure 6. Others Product Picture

    Figure 7. Global NK Cells Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global NK Cells Market Share by Application in 2022 & 2029

    Figure 9. Cancer

    Figure 10. Cardiovascular Diseases

    Figure 11. Others

    Figure 12. Global NK Cells Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global NK Cells Market Size (2018-2029) & (US$ Million)

    Figure 14. Global NK Cells Sales (2018-2029) & (g)

    Figure 15. Global NK Cells Average Price (USD/g) & (2018-2029)

    Figure 16. NK Cells Report Years Considered

    Figure 17. NK Cells Sales Share by Manufacturers in 2022

    Figure 18. Global NK Cells Revenue Share by Manufacturers in 2022

    Figure 19. The Global 5 and 10 Largest NK Cells Players: Market Share by Revenue in 2022

    Figure 20. NK Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 21. Global NK Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 22. North America NK Cells Sales Market Share by Country (2018-2029)

    Figure 23. North America NK Cells Revenue Market Share by Country (2018-2029)

    Figure 24. U.S. NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Canada NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Europe NK Cells Sales Market Share by Country (2018-2029)

    Figure 27. Europe NK Cells Revenue Market Share by Country (2018-2029)

    Figure 28. Germany NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. France NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. U.K. NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Italy NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Russia NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Asia Pacific NK Cells Sales Market Share by Region (2018-2029)

    Figure 34. Asia Pacific NK Cells Revenue Market Share by Region (2018-2029)

    Figure 35. China NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Japan NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. South Korea NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. India NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Australia NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Taiwan NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Indonesia NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Thailand NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Malaysia NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Philippines NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America NK Cells Sales Market Share by Country (2018-2029)

    Figure 46. Latin America NK Cells Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa NK Cells Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa NK Cells Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. U.A.E NK Cells Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of NK Cells by Type (2018-2029)

    Figure 56. Global Revenue Market Share of NK Cells by Type (2018-2029)

    Figure 57. Global NK Cells Price (USD/g) by Type (2018-2029)

    Figure 58. Global Sales Market Share of NK Cells by Application (2018-2029)

    Figure 59. Global Revenue Market Share of NK Cells by Application (2018-2029)

    Figure 60. Global NK Cells Price (USD/g) by Application (2018-2029)

    Figure 61. NK Cells Value Chain

    Figure 62. NK Cells Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed